Skip to main content

UBS Group AG

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in SUPN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$10,809,618
+$8,670,183 QoQ
Shares Held
209,124
+385.8% QoQ
Ownership
0.360%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 94.70409900346206.ToString("F0")% Shared 0.ToString("F0")% None 5.295900996537939.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,524,475,453 across 81 Drug Manufacturers - Specialty & Generic names. SUPN ranks #20 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SUPN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,809,618 209,124
2025-12-31 $2,139,435 43,047
2025-09-30 $25,812,477 540,123
2025-06-30 $7,166,008 227,348
2025-03-31 $8,197,848 250,316
2024-12-31 $7,232,939 200,026
2024-09-30 $3,394,190 108,858
2024-06-30 $2,142,299 80,086
2024-03-31 $2,201,595 64,544
2023-12-31 $1,893,225 65,419
2023-09-30 $524,629 19,029
2023-06-30 $1,620,623 53,913
2023-03-31 $1,435,975 39,635
2022-12-31 $1,000,971 28,062
2022-09-30 $255,398 7,545
2022-06-30 $45,809 1,584
2022-03-31 $2,707,252 83,764
2021-12-31 $2,886,810 98,999
2021-09-30 $81,289 3,048
2021-06-30 $743,362 24,143
2021-03-31 $4,585,400 175,149
2020-12-31 $4,563,571 181,382
2020-09-30 $349,486 16,770
2020-06-30 $705,778 29,717
2020-03-31 $734,494 40,828